News

Introduction Computational drug design typically requires a well-defined protein-ligand complex.

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to

Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify

Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is

On Tuesday, October 1, PolarisQB hosted a webinar titled "Find

OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on

PolarisQB is happy to announce the integration of Virtual Libraries and

Quantum-Aided Drug Design (QuADD) is delivering value to our customers

On Friday, May 17, PolarisQB hosted a group of thought

POLARISqb, a company revolutionizing drug design by joining quantum computing